Turning Point Brands narrows 2026 EBITDA forecast to $70 million - $80 million

Turning Point Brands reaffirmed its full-year 2026 Modern Oral gross sales guidance of $330 million-$350 million and net sales outlook of $260 million-$270 million. The company narrowed its EBITDA guidance to $70 million-$80 million from $70 million-$90 million, assuming no margin benefit from onshoring manufacturing until 2027 and reflecting expectations for prolonged, higher freight costs.